AUG 07, 2018 8:50 PM PDT

Improving Liver Cancer Therapy

WRITTEN BY: Nouran Amin

According to studies conducted in the United States, the ninth leading causes of cancer deaths is hepatocellular carcinoma, the primary cancer of the liver. Hepatocellular carcinoma tends to grow and expand at an increasingly fast rate and if not diagnosed early on then affected individuals may not always survive longer than 11 months. Specialists seek to treat their patients by usually prescribing a therapeutic drug known as "sorafenib." However, the drug will typically prolong the survival of individuals by only 3 months, and it can bring numerous negative side-effects.

Watch Alternative Treatment Options:

To seek other options in an effort to improve liver cancer treatment, cancer researchers from multiple international institutions have collaborated together to treat a therapeutic drug that holds high efficacy for the treatment of liver cancer. The compound was developed primarily by researchers from the Cancer Institute of Singapore at the National University of Singapore in Queenstown along with colleagues from other global institutions.

The new experimental drug, which researchers refer to as "FFW", holds the potential to treat liver cancer by improving survival rates and lessening adverse effects additionally it is believed to alter the growth of primary liver cancer and help reduce the unwanted effects of typical therapy. In the journal PNAS, the development of FFW is outlined by the researchers in the most recent publication. "In our latest work, [we have] demonstrated an effective strategy to accurately target oncogenes previously considered undruggable," says study co-author and professor at the National University of Singapore, Daniel Tenen.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 20, 2020
Drug Discovery & Development
Hyperbaric Oxygen Treatments Reverse Aging
NOV 20, 2020
Hyperbaric Oxygen Treatments Reverse Aging
Researchers from Israel have found that hyperbaric oxygen treatments (HBOT) in healthy aging adults can prevent blood ce ...
NOV 26, 2020
Cardiology
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
NOV 26, 2020
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
Cardiovascular disease and diabetes are often associated with each other, as many issues caused by diabetes promote hear ...
NOV 22, 2020
Cannabis Sciences
Public Believes CBD is Cure-All Despite Lack of Evidence
NOV 22, 2020
Public Believes CBD is Cure-All Despite Lack of Evidence
Many people think that cannabidiol (CBD), a non-psychoactive compound in cannabis, can reduce symptoms from various cond ...
DEC 30, 2020
Drug Discovery & Development
Gene Therapy Cures Mice of Deafness
DEC 30, 2020
Gene Therapy Cures Mice of Deafness
Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic ...
Loading Comments...